Treatment of cutaneous larva migrans with albendazole. Preliminary report.
Rev Inst Med Trop Sao Paulo
; 31(1): 56-8, 1989.
Article
em En
| MEDLINE
| ID: mdl-2814206
Twenty three patients with Cutaneous Larva Migrans syndrome were prospectively treated with 400 mg/day of Albendazole for 3 consecutive days. Clinical response, compliance and tolerance was excellent. Patients were asymptomatic within the first 72 hours of treatment and recurrences did not occurred. Preliminary results with three additional patients suggest that a single oral 400 mg dose may be effective as well.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Larva Migrans
/
Albendazol
/
Anti-Helmínticos
Limite:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Rev Inst Med Trop Sao Paulo
Ano de publicação:
1989
Tipo de documento:
Article
País de publicação:
Brasil